Bicara Therapeutics Inc
(BCAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,564 | -64,234 | -36,846 | -67,995 | -47,038 |
| Depreciation Amortization | 94 | 38 | 19 | 56 | 41 |
| Other Working Capital | 6,367 | 3,204 | 5,132 | -14,132 | -2,137 |
| Other Operating Activity | 11,155 | 7,292 | 3,589 | 7,320 | 4,415 |
| Operating Cash Flow | $-82,948 | $-53,700 | $-28,106 | $-74,751 | $-44,719 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | N/A | N/A | -9 | 31 |
| Purchase Of Investment | -236,079 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-236,121 | $N/A | $N/A | $-9 | $31 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,031 | 595 | 460 | 334,031 | 335,006 |
| Financing Cash Flow | $1,031 | $595 | $460 | $334,031 | $335,006 |
| Beginning Cash Position | 489,711 | 489,711 | 489,711 | 230,440 | 230,440 |
| End Cash Position | 171,673 | 436,606 | 462,065 | 489,711 | 520,758 |
| Net Cash Flow | $-318,038 | $-53,105 | $-27,646 | $259,271 | $290,318 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,948 | -53,700 | -28,106 | -74,751 | -44,719 |
| Capital Expenditure | -42 | 0 | 0 | -71 | -31 |
| Free Cash Flow | -82,990 | -53,700 | -28,106 | -74,822 | -44,750 |